Filing Details
- Accession Number:
- 0001062993-22-011322
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-03 08:31:43
- Reporting Period:
- 2022-04-29
- Accepted Time:
- 2022-05-03 08:31:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
75252 | Owens & Minor Inc | OMI | Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) | 541701843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1789650 | J Robert Henkel | Owens &Amp; Minor, Inc. 9120 Lockwood Blvd Mechanicsville VA 23116 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-02 | 2,000 | $35.00 | 26,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Phantom Stock | Acquisiton | 2022-04-29 | 1 | $35.49 | 1 | $0.00 |
Common Stock | Phantom Stock | Acquisiton | 2022-04-29 | 4,931 | $0.00 | 4,931 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
42,070 | No | 4 | A | Direct | ||
47,001 | No | 4 | A | Direct |
Footnotes
- The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020.
- The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).
- Shares acquired through quarterly dividend reinvestment transaction.